<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20111122008170N14</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-01-29</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of health promotion awareness counseling with stress management on anxiety and reproductive and sexual  self-care performance in women with human papiloma virus</public_title>
      <acronym></acronym>
      <scientific_title>The effect of health promotion awareness counseling with stress management on anxiety and reproductive and sexual  self-care performance in women with human papiloma virus : a controlled clinical randomized trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-02-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74823</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The women participating in the research will be assigned to two groups receiving counseling and the control group through 4 and 6 blocks with a ratio of 1:1 through 4 and 6 blocks using RAS software. The type of allocation will be written on paper and will be provided to the responsible author (the first guidance teacher) and the allocation of people to the intervention and control groups will be done by the same person in a central way (allocation concealment), Blinding description: The person analyzing the data will not be aware of the type of group assignment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>anxiety.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: For the intervention group (32 people), six group counseling sessions (4-6 people) will be held for 60-90 minutes in one of the clinic rooms of Al-Zahra Hospital. In between the counseling sessions, the researcher will be in contact with the participants through telephone follow-ups so that they can participate in the counseling sessions on a regular basis. The researcher will provide his contact number to both intervention and control groups to answer the questions. The control group will receive routine care. If the positive effect of this approach in reducing anxiety and improving self-care performance in the intervention group is confirmed at the end of the study, counseling sessions will also be provided for the control group. The post-test questionnaires including Spielberger's anxiety, self-care and reproductive and sexual health literacy, and quality of life and stress will be completed by self-administered method. In case of incomplete participation in counseling sessions, the questionnaires will be completed and analyzed as Intention to Threat. Also, the missing cases will be investigated with the multiple imputation policy. Intervention 2: Control group: . The control group will receive routine care. If the positive effect of this approach in reducing anxiety and improving self-care performance in the intervention group is confirmed at the end of the study, counseling sessions will also be provided for the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>malakouti.jamileh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Shariati Street, Faculty of Nursing and Midwifery</address>
        <city>tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>66156-15733</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>jamilehmalakouti@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Malakouti.Jamileh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, South Shariati Street, Tabriz</address>
        <city>tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>66156-15733</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>jamilehmalakouti@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women with positive HPV test results and low-risk and high-risk groups
Anxiety score 32-64
Having a contact number for follow-up
Literacy for reading and writing</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Cancer disease or its history
History of participating in previous training and intervention programs related to sexual health and fertility
intellectual disability
Any mental illness according to the person's statement
Any recent unfortunate incident including the loss of a loved one within the last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F06.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anxiety disorder due to known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: For the intervention group (32 people), six group counseling sessions (4-6 people) will be held for 60-90 minutes in one of the clinic rooms of Al-Zahra Hospital. In between the counseling sessions, the researcher will be in contact with the participants through telephone follow-ups so that they can participate in the counseling sessions on a regular basis. The researcher will provide his contact number to both intervention and control groups to answer the questions. The control group will receive routine care. If the positive effect of this approach in reducing anxiety and improving self-care performance in the intervention group is confirmed at the end of the study, counseling sessions will also be provided for the control group. The post-test questionnaires including Spielberger's anxiety, self-care and reproductive and sexual health literacy, and quality of life and stress will be completed by self-administered method. In case of incomplete participation in counseling sessions, the questionnaires will be completed and analyzed as Intention to Threat. Also, the missing cases will be investigated with the multiple imputation policy.</i_keyword>
      <i_keyword>Control group: . The control group will receive routine care. If the positive effect of this approach in reducing anxiety and improving self-care performance in the intervention group is confirmed at the end of the study, counseling sessions will also be provided for the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Average anxiety score. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: Spielberger anxiety questionnaire.</prim_outcome>
      <prim_outcome>Mean score of fertility and sexual self-care performance. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: assessment questionnaire Reproductive and sexual self-care.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sexual health literacy. Timepoint: Before the intervention and 4 weeks after the study. Method of measurement: Sexual health literacy questionnaire for adults, SHALE.</sec_outcome>
      <sec_outcome>Quality of Life. Timepoint: Before the intervention and 4 weeks after the study. Method of measurement: Quality of life questionnaire for women with HPV (HPV‑QoL Human Papilloma Viral questionnaire).</sec_outcome>
      <sec_outcome>Stress. Timepoint: Before the intervention and 4 weeks after the study. Method of measurement: DASS-21 questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-01-10</approval_date>
        <contact_name>Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Golgasht Street, Tabriz University of Medical Sciences Vice President of Research and Technology tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
